VarCT’s Director of Discovery and Preclinical Development, Dr. Mette Ørskov Agerbæk, are to present new exciting data on capturing of CTCs at the 11^th International Symposium on Minimal Residual Cancer in Montpellier, France. The poster, entitled “The rVAR2 malaria protein efficiently retrieves circulating tumor cells in a EpCAM-independent manner” and is on display at the congress in poster session 2 on Thursday, May 3^rd. Check it out!